JPRN-jRCT2052210099招募中2 期
A single-center assessor-blinded trial to investigate the efficacy and safety of microwave mammography IGS-0001 in patients with breast cancer and healthy women
Takao Shintaro0 个研究点目标入组 10 人开始时间: 2021年10月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable(—)
- 性别
- Female
入选标准
- •Breast cancer (including suspected)
- •(1) One of the following applies
- •(a) Histologically diagnosed breast cancer by needle biopsy or fine-needle aspiration cytology
- •(b) Patients who are suspected of having breast cancer based on an examination using a mammographic image diagnostic system or mammary ultrasonography.
- •(2) The patient is a woman 20 years of age or older at the time of obtaining consent.
- •(3) Japanese women.
- •(4) Patients who agree to participate in the study of their own free will after receiving sufficient explanation of the contents of the study from the investigator or sub-investigator using the consent document and the explanation document.
- •No breast cancer or suspicion of breast cancer
- •(1) No history of breast cancer.
- •(2) Have never been suspected of having breast cancer during screening using a mammographic image diagnostic system or mammary ultrasonography.
- •(3) If the patient has undergone a screening using a diagnostic mammography system in the six months prior to the date of consent, the most recent images of the screening using a diagnostic mammography system can be collected.
- •(4) The patient must be 20 years of age or older at the time of consent.
- •(5) The subjects must be Japanese women.
- •(6) The patient has received a full explanation of the contents of the study from the investigator or sub-investigator using the consent document and the explanation document, and freely and voluntarily agrees to participate in the study.
排除标准
- •(1) There is trauma with bleeding on the breast surface.
- •(2) There is an artificial object such as silicone inserted into the breast.
- •(3) It has not been more than 7 days since the needle biopsy or aspiration-assisted needle biopsy was performed.
- •(4) Medication is being administered.
- •(5) The patient has an implantable device such as a pacemaker.
- •(6) The patient has a fever and is suspected to be infected.
- •(7) Has a history of or is undergoing treatment for a serious psychiatric disorder, and the investigator or sub-investigator judges that it is difficult for the patient to participate in this study.
- •(8) There is a possibility of pregnancy.
- •(9) The subject is pregnant.
- •(10) I am breastfeeding.
- •(11) It is impossible to keep the patient lying on the bed during IGS-0001 (about 20 minutes).
- •(12) Unable to keep his or her arms raised to the head for about 10 minutes during IGS-0001.
- •(13) In addition, the investigator or sub-investigator judges that the subject is unsuitable.
研究者
相似试验
已完成
不适用
A single-center, single-blind study to investigate skin response to sub-therapeutic doses of taspoglutide in GLP-1 analogue naive healthy volunteersdiabetesNL-OMON34382Hoffmann-La Roche6
尚未招募
3 期
A clinical trial to study the effects of homoeopathic medicine causticum on cases of warts through an external and internal applicatioCTRI/2022/04/041696Dr Sangram Arun Jadhav
招募中
不适用
Effect of education and exercise in patient with Ankylosing Spondylitisankylosing spondylitis.Ankylosing spondylitisIRCT20191015045119N2Tehran University of Medical Sciences45
招募中
4 期
A clinical trial to study the effect of prophylactic vitamin D supplementation in children with severe acute malnutritioCTRI/2016/07/007077SN CHILDREN HOSPITA70
进行中(未招募)
1 期
A single-center controlled pilot study to investigate pre- and perioperative therapy with Sorafenib (Nexavar®) in patients who are candidates for a curative surgery of renal cell cancer (PREST = preoperative Sorafenib Therapy in RCC) - PRESTEUCTR2008-002667-13-DEniversity Clinic of Heidelberg40
